Aprogen Biologics

003060 · KOSPI · Health Care · SMALL CAP

Results of rights offering or equity-linked bond issuance (voluntary)

Aprogen Biologics, Inc. completed a third-party-allotment rights offering of 1,087,548 common shares for US$1.37M, fully paid in on July 27, 2026, following a board resolution on July 14, 2026.

Capital raise(Results of rights offering or equity-linked bond issuance (voluntary))· FILED 2026-07-27· RCEPT 20260727800203

What happened

Aprogen Biologics, Inc. / Results of Rights Offering or Equity-Linked Bond Issuance, etc. (Voluntary Disclosure) / (2026.07.27)

1. Type of security: registered common shares 2. Issue method: third-party-allotment rights offering 3. Issuance details: planned issue shares 1,087,548; planned issue amount KRW 2,000,000,772; initial board resolution date 2026-07-14; actual issue shares 1,087,548; actual issue amount KRW 2,000,000,772; payment date 2026-07-27

4. Other matters of reference for investment decisions: none

Related disclosure: 2026-07-14 Rights offering decision.

Filed2026-07-27, Results of rights offering or equity-linked bond issuance (voluntary)
SourceDART rcept 20260727800203 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-27 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).